News and Trends 9 Dec 2015
CAR-T Phase II: 93% Complete Remission in Children with Relapsed Leukemia!
Wow! 55 of 59 patients in a Novartis trial experienced complete remission in one of the largest investigational CAR-T therapies…
Cellectis
- Latest Posts
News and Trends 30 Nov 2015
Cellectis’ CEO: “I’m just trying to be realistic, CAR-T is not THE miracle cure for Cancer”
CAR-T is solidifying in everybody's mind as the next revolution in Cancer treatment. But there is still a lot to…
News and Trends 19 Nov 2015
Why has the Universal CAR-T Treatment For Leukemia Hooked TWO Big Pharmas at Once?
French Servier and Pfizer have already had independent partnerships with Cellectis on various R&D areas. But now the two have…
News and Trends 7 Nov 2015
What Happened this Week? BIO-Europe 2015, mRNA deal, Cellectis CAR-T
Monday: The French Scientist Who Also ‘Discovered’ CRISPR is Finally Recognized with a Prize too Tuesday: €100 Million Investment Round Prepares…
ADVERTISEMENT
News and Trends 6 Nov 2015
Cellectis’ Miraculous Saving of a Baby Girl. What’s the impact on the CAR-T field?
About 30%. That's how Cellectis' NASDAQ stock price has jumped between the 4th and the 5th of November. But why? Basically,…
News and Trends 29 Oct 2015
Cellectis UCART Milestone: One step closer to a Universal CAR-T Therapy for Blood Cancer
Cellectis is a leader in immuno-oncology CAR-T therapies from France, which might revolutionise cancer treatments. Now, the next step in…
News and Trends 15 Sep 2015
The 9 EU-based Billion-Euro Biotechs you Should (really) Know
Update 22/10/2015: I added Galapagos from Belgium and Basilea from Switzerland, they deserved it ... Talking about billon-dollar companies in…
News and Trends 19 Aug 2015
Paris is Europe’s biggest Biocluster, but nobody knows it …
Paris is well-known for being the most beautiful city in the world. But did you also know that it concentrates…
News and Trends 15 Jul 2015
How Servier saved Cellectis, the French CAR-T Miracle
Cellectis, the €1bn CAR-T company, just announced it reached a significant milestone in its collaboration with Servier. Surprisingly, early 2014, Cellectis…
News and Trends 25 Jun 2015
Video: Discover How CAR-T Therapies are Working
It's becoming a habit for us to talk about CAR-T therapies. It's basically the next wave of treatments against cancer…
ADVERTISEMENT
News and Trends 29 May 2015
Pfizer to Control Cellectis in a €1.5 Billion Deal?
Rumors are saying that French Cellectis is in talks about its potential sale. US-giant Pfizer is considered to be among…
News and Trends 26 Mar 2015
With €200 Million, Cellectis is on its way to make the Biggest French Biotech IPO ever
Exactly one month ago, the article "Cellectis is preparing its IPO in the U.S" explained Cellectis prepared an IPO to…
News and Trends 25 Feb 2015
Cellectis is preparing its IPO in the U.S
Cellectis is a company focused on developing immunotherapies based on gene edited engineered CAR-T cells. The company’s mission is to…
News and Trends 21 Jan 2015
Review: The CRISPR’s Therapeutical revolution
Six years ago, a new sophisticated prokaryotic defense system, was identified in the structure complex CRISPR-Cas9 (CRISPR, clustered regularly interspaced…
